About Bright Uro
Bright Uro is a company based in Aliso Viejo (United States) founded in 2021 by Derek Herrera. Bright Uro has raised $94.99 million across 8 funding rounds from investors including NIH, Laborie Medical and HHS. The company has 23 employees as of December 31, 2024. Bright Uro operates in a competitive market with competitors including DNC Biotechnology, Clinical Design, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others.
- Headquarter Aliso Viejo, United States
- Employees 23 as on 31 Dec, 2024
- Founders Derek Herrera
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Bright Uro, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$94.99 M (USD)
in 8 rounds
-
Latest Funding Round
$15 M (USD), Series A
Jun 20, 2025
-
Investors
NIH
& 8 more
-
Employee Count
23
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Bright Uro
Unlock access to complete
Funding Insights of Bright Uro
Bright Uro has successfully raised a total of $94.99M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bright Uro
Bright Uro has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include NIH, Laborie Medical and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Administers health care and support for military personnel and operations.
|
Locked | Locked | Locked |
Investor details for Bright Uro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bright Uro
Investment portfolio details for Bright Uro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bright Uro
Detailed financials for Bright Uro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bright Uro Comparisons
Peer comparison for Bright Uro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bright Uro
Bright Uro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNC Biotechnology, Clinical Design, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro diagnostic devices for urine infection detection are developed.
|
|
| Locked | Locked | Locked |
A patented urine diagnostic device for ten parameters is developed.
|
|
| Locked | Locked | Locked |
Uro-flow meters for LUTS diagnosis and patient care are provided.
|
|
| Locked | Locked | Locked |
High-throughput clinical analyzers, microscopes, and glucometers are developed and manufactured.
|
|
| Locked | Locked | Locked |
Provides DIY test kits for benign prostatic hyperplasia (BPH).
|
Detailed competitors of Bright Uro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bright Uro
Complete news archive for Bright Uro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bright Uro
Bright Uro was founded in 2021.
Bright Uro is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Derek Herrera is the current CEO of Bright Uro. They have also founded this company.
Bright Uro is a funded company, having raised a total of $94.99M across 8 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Bright Uro is 23.
Bright Uro was founded in 2021 and is headquartered in Aliso Viejo, United States. Operations center on the medical device sector, specifically urology diagnostics. The Glean Urodynamics System is offered, which includes an insertion tool, a Bluetooth-enabled pressure sensor within a flexible silicone tube, a software application, and a uroflowmeter for measuring volume and flow rates. Focus remains on tools for lower urinary tract disease assessment.
Bright Uro's top competitors include DNC Biotechnology, Clinical Design and Stream DX.
Bright Uro has 9 investors. Key investors include NIH, Laborie Medical, HHS, University of California, and Military Health.